Recombinant IL6R (Satralizumab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target
- IL6R (Satralizumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
- Host
-
Mammalian Cells
- Expression System
- Mammalian cells
- Clonality
- Monoclonal
- Application
- ELISA
- Purpose
- Satralizumab Biosimilar - Anti-IL6R mAb
- Characteristics
- Antibody Type: IgG2-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Grade
- Research Grade
- Isotype
- IgG2 kappa
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- IL6R (Satralizumab Biosimilar)
- Target Type
- Biosimilar
- Background
-
SA-237
Satralizumab (SA237), a humanized IgG2 targeting interleukin-6 (IL-6) receptor (IL-6R). - CAS-No
- 1535963-91-7
-
You are here:
